Mean disease-specific survival, standard error (SE) and 95% CI for patients with colorectal cancer in relation to major histocompatibility complex (MHC) class I and intratumoral T cell (ITTC) expression
| MHC class I/ITTC | Mean disease-specific survival | |||
| Estimate (months) | SE | 95% CI | ||
| Lower | Upper | |||
| Negative MHC I/low ITTC | 64.4 | 10.1 | 44.6 | 84.1 |
| Negative MHC I/high ITTC | 55.7 | 11.01 | 34.1 | 77.3 |
| Weak MHC I/low ITTC | 46.4 | 6.6 | 33.5 | 59.3 |
| Weak MHC I/high ITTC | 67.6 | 5.3 | 57.4 | 77.9 |
| Strong MHC I/low ITTC | 52.9 | 7.1 | 39.0 | 66.9 |
| Strong MHC I/high ITTC | 72.5 | 4.5 | 63.8 | 81.3 |
| Overall | 65.8 | 2.7 | 59.4 | 70.1 |